Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Oxygen regulates molecular mechanisms of cancer progression and metastasis.

Gupta K, Madan E, Sayyid M, Arias-Pulido H, Moreno E, Kuppusamy P, Gogna R.

Cancer Metastasis Rev. 2013 Dec 15. [Epub ahead of print]

PMID:
24338006
[PubMed - as supplied by publisher]
2.

A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma.

Bauman JE, Arias-Pulido H, Lee SJ, Fekrazad MH, Ozawa H, Fertig E, Howard J, Bishop J, Wang H, Olson GT, Spafford MJ, Jones DV, Chung CH.

Oral Oncol. 2013 May;49(5):461-7. doi: 10.1016/j.oraloncology.2012.12.016. Epub 2013 Feb 4.

PMID:
23384718
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer.

Bauman JE, Eaton KD, Wallace SG, Carr LL, Lee SJ, Jones DV, Arias-Pulido H, Cerilli LA, Martins RG.

BMC Cancer. 2012 Oct 3;12:449. doi: 10.1186/1471-2407-12-449.

PMID:
23033932
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer.

Arias-Pulido H, Chaher N, Gong Y, Qualls C, Vargas J, Royce M.

BMC Cancer. 2012 Jul 19;12:298. doi: 10.1186/1471-2407-12-298.

PMID:
22813402
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

DR6 as a diagnostic and predictive biomarker in adult sarcoma.

Yang K, Mooney C, Spahlinger G, Schuetze S, Arias-Pulido H, Verschraegen C, Gimotty P, Buckanovich RJ.

PLoS One. 2012;7(5):e36525. doi: 10.1371/journal.pone.0036525. Epub 2012 May 2.

PMID:
22567163
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen.

Verschraegen CF, Arias-Pulido H, Lee SJ, Movva S, Cerilli LA, Eberhardt S, Schmit B, Quinn R, Muller CY, Rabinowitz I, Purdy M, Snyder D, Bocklage T.

Ann Oncol. 2012 Mar;23(3):785-90. doi: 10.1093/annonc/mdr299. Epub 2011 Jul 11.

PMID:
21746804
[PubMed - indexed for MEDLINE]
Free Article
7.

Mesothelin and GPR30 staining among a spectrum of pancreatic epithelial neoplasms.

Glass JP, Parasher G, Arias-Pulido H, Donohue R, Prossnitz ER, Cerilli LA.

Int J Surg Pathol. 2011 Oct;19(5):588-96. doi: 10.1177/1066896911409575. Epub 2011 Jun 1. Erratum in: Int J Surg Pathol. 2012 Apr;20(2):211.

PMID:
21632639
[PubMed - indexed for MEDLINE]
8.

Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.

Chaher N, Arias-Pulido H, Terki N, Qualls C, Bouzid K, Verschraegen C, Wallace AM, Royce M.

Breast Cancer Res Treat. 2012 Jan;131(2):437-44. doi: 10.1007/s10549-011-1422-5. Epub 2011 Mar 1.

PMID:
21360074
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Epidermal growth factor receptor as a biomarker for cervical cancer.

Soonthornthum T, Arias-Pulido H, Joste N, Lomo L, Muller C, Rutledge T, Verschraegen C.

Ann Oncol. 2011 Oct;22(10):2166-78. doi: 10.1093/annonc/mdq723. Epub 2011 Feb 16. Review.

PMID:
21325449
[PubMed - indexed for MEDLINE]
Free Article
10.

Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma.

Huang GS, Gunter MJ, Arend RC, Li M, Arias-Pulido H, Prossnitz ER, Goldberg GL, Smith HO.

Am J Obstet Gynecol. 2010 Sep;203(3):242.e1-5. doi: 10.1016/j.ajog.2010.04.046. Epub 2010 Jun 3.

PMID:
20605134
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer.

Huang GS, Brouwer-Visser J, Ramirez MJ, Kim CH, Hebert TM, Lin J, Arias-Pulido H, Qualls CR, Prossnitz ER, Goldberg GL, Smith HO, Horwitz SB.

Clin Cancer Res. 2010 Jun 1;16(11):2999-3010. doi: 10.1158/1078-0432.CCR-09-3233. Epub 2010 Apr 19.

PMID:
20404007
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer.

Arias-Pulido H, Royce M, Gong Y, Joste N, Lomo L, Lee SJ, Chaher N, Verschraegen C, Lara J, Prossnitz ER, Cristofanilli M.

Breast Cancer Res Treat. 2010 Aug;123(1):51-8. doi: 10.1007/s10549-009-0631-7. Epub 2009 Nov 10.

PMID:
19902352
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.

Narayan G, Scotto L, Neelakantan V, Kottoor SH, Wong AH, Loke SL, Mansukhani M, Pothuri B, Wright JD, Kaufmann AM, Schneider A, Arias-Pulido H, Tao Q, Murty VV.

Genes Chromosomes Cancer. 2009 Nov;48(11):983-92. doi: 10.1002/gcc.20703.

PMID:
19681120
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.

Arias-Pulido H, Smith HO, Joste NE, Bocklage T, Qualls CR, Chavez A, Prossnitz ER, Verschraegen CF.

Gynecol Oncol. 2009 Sep;114(3):480-5. doi: 10.1016/j.ygyno.2009.05.045. Epub 2009 Jun 27.

PMID:
19560192
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

GPR30 predicts poor survival for ovarian cancer.

Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER.

Gynecol Oncol. 2009 Sep;114(3):465-71. doi: 10.1016/j.ygyno.2009.05.015. Epub 2009 Jun 6.

PMID:
19501895
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Novel chemotherapy approaches for cervical cancer.

Movva S, Rodriguez L, Arias-Pulido H, Verschraegen C.

Cancer. 2009 Jul 15;115(14):3166-80. doi: 10.1002/cncr.24364. Review.

PMID:
19452541
[PubMed - indexed for MEDLINE]
Free Article
17.

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha.

Scotto L, Narayan G, Nandula SV, Subramaniyam S, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, Schneider A, Arias-Pulido H, Murty VV.

Mol Cancer. 2008 Jun 17;7:58. doi: 10.1186/1476-4598-7-58.

PMID:
18559093
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.

Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, Murty VV.

Genes Chromosomes Cancer. 2008 Sep;47(9):755-65. doi: 10.1002/gcc.20577.

PMID:
18506748
[PubMed - indexed for MEDLINE]
19.

Absence of epidermal growth factor receptor mutations in cervical cancer.

Arias-Pulido H, Joste N, Chavez A, Muller CY, Dai D, Smith HO, Verschraegen CF.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):749-54. Epub 2007 Oct 19.

PMID:
17949425
[PubMed - indexed for MEDLINE]
20.

Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.

Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Dürst M, Schneider A, Pothuri B, Mansukhani M, Basso K, Chaganti RS, Murty VV.

Genes Chromosomes Cancer. 2007 Apr;46(4):373-84.

PMID:
17243165
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk